Treatment of anejaculation in the total paraplegic by subcutaneous injection of Physostigmine.
The authors describe a new therapy for paraplegic anejaculation. Sub-cutaneous injection of Physostigmine with certain precautions and with selected methods of application can be used for patients where there is the same indication for the use of an intrathecal injection of Neostigmine. The T12-L2 myelomeres must be intact. The new treatment is easier to perform, and when the patient has experimented with three tests in our hospital without any problems, he is granted permission to apply this treatment at home, without any medical supervision.
D000293:Adolescent; D000328:Adult; D004542:Ejaculation / Q000187:drug effects*; D005832:Genital Diseases, Male / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000627:therapeutic use; D010264:Paraplegia / Q000150:complications* / Q000503:physiopathology; D010830:Physostigmine / Q000627:therapeutic use*
D009388:Neostigmine; D010830:Physostigmine